SAVE THE DATE- October 17, 2009
NJ Plans One Day Conference The New Jersey Carcinoid Cancer Network has been at work putting together a one day lecture event being held on October 17th, 2009. This will be the first lecture held in New Jersey and we have chosen a location that is not only easy to get to, but fun to be at.
The place is Manahawkin, NJ. In “New Jersey Speak” that’s Parkway “exit 58” (as in “what exit?). This is only a few minutes from Long Beach Island, home to some of the best beaches in New Jersey...........Read more in the NJ's Newsletter.
May 29 - June 2. 2009 Exhibit dates Saturday and Sunday May 30, 31 and Monday June 1
(From 9:00 am - 5:00 pm) Orlando, FL The CCF, together with CCAN and representatives from NANETS, ENETS,members from various US support and advocacy groups again for the third time exhibited at the 45th ASCO Annual Meeting (ASCO= the American Society for Clinical Oncologists).
Oncology nurses, pharmacists, genetic counselors and other health care professionals in related fields attend ASCO’s Annual Meeting. Educational and scientific sessions at the Meeting offer cutting-edge information on the diagnosis and treatment of patients with cancer.About 24,000 medical professionals from the US and many other countries attended.
AGENDA
Guest speakers: J. Philip Boudreaux, M.D., FACS (Surgical Oncolgist)
Professor of Surgery, LSUHSC, Kenner, LA Rodney Pommier, M.D. (Surgical Oncologist)
Professor of Surgery
Oregon Health & Science UniversityPortland, OR. Patient Section 3 pm -5 pm: Survival Stories and Networking Living with a Rare Disease (Panel discussion)
Patients and caregivers perspectives
SPAIN 2009
ENETS' Board of Directors ENETS The European Neuroendocrine
Tumor Society held its 6th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 5-7 March 2009 in Granada, Spain.
> 700 physicians from all over the world attended this meeting
The Carcinoid Cancer Foundation(CCF) was represented by
(from left)Drs Curran, Shafir and Warner, from MSH, NYC presenting a
CCF sponsored reserarch project
"Serum and Ascites Chromogranin A in patients with Metastatic Neuroendocrine Tumors"
Drs Curran, Shafir and Warner, from MSH, NYC
Thank you Maureen and CNETS team for a splendid job.
Maureen Coleman at maureenc@sympatico.ca
Go to
CNETS' website http://www.cnetscanada.org/ for more information and get to know the people behind this marvelous group.
EDUCATING THE GLOBAL MEDICAL COMMUNITY / AT THE 44TH ASCO MEETING The CCF, together with CCAN and representatives from NANETS, ENETS,CNETS-Canada, andmembers from various US support and advocacy groups, exhibited again at the 44th ASCO Annual Meeting (ASCO= the American Society for Clinical Oncologists).
Oncology nurses, pharmacists, genetic counselors and other health care professionals in related fields attend ASCO’s Annual Meeting. Educational and scientific sessions at the Meeting offer cutting-edge information on the diagnosis and treatment of patients with cancer.About 30,000 medical professionals from the US and many other countries attended.
The annual Meeting was held on May 30 - June 3, 2008 at the McCormick Place, Chicago, Illinois.
Exhibitor List The CCF and CCAN had reserved very prominent spaces this year see map HERE
Hover over space 3002 and 3004 and you will see our location. TOGETHER WE WILL MAKE A DIFFERENCE
CCF 11th Annual Carcinoid/NET's Conference
For patients, caretakers and medical professionals "Progress in Research and Treatment" (poster)
April 13, 2008
Mount Sinai Hospital
New York, NY
Guest Speakers: Herbert Chen, M.D., University of Wisconsin Paul P. Carbone
Comprehensive Cancer Center
Madison, Wisconsin Andrew S. Kennedy, M.D.,Wake Radiology Oncology
Cary,NC; Networking and survivor stories
To view and listen to video recordings CLICK HERE
To view pictures from this successful event CLICK HERE
ENETS (European
NeuroEndocrine Society) The 5th Annual ENETS conference was held on 6-8
March 2008 in Paris. The ENETS Executive Committee presented the following topics in ther program
; Test TNM cases;
modeling MEN X; minimal requirements for work-up and diagnosis;
pitfalls in NET diagnosis and treatment; and, inherited tumors
This meeting included two abstract sessions, one for basic
science, the other for clinical research.
CCF
Exhibits at the ASCO Annual Meeting
43rd ASCO (the American Society for Clinical Oncology) Annual Meeting was held on June 1-5, 2007 McCormick Place
Chicago, Illinois CCF was invited for the second time to exhibit at the
(ASCO) Annual Conference in Chicago, June 2-4, 2007. Following
one of CCF's missions,
"If you don't suspect it, you can't detect it," the A
-TEAM, consisting of patients, caretakers and patient advocates,
educated many of the 35,000 attending health care professionals
(HCP).
SLIDE SHOW: http://www.flickr.com/photos/mewarner/sets/72157600346475209/show/
PICTURE PAGE: http://www.flickr.com/photos/mewarner/sets/72157600346475209/
On June 3-5, 2006 CCF exhibited at the ASCO Conference
in Atlanta, GA Educating the physicians from all over the world in
More than 1000 HCPs visited our booth in 2006
To view Slide show from the 2006 exhibit CLICK
HERE
To find out who is who click on each picture and you will get more
details
The Carcinoid Cancer Foundation presented Carcinoids:
The Slow Pace of Rapid Progress on April 15, 2007,
at Mount Sinai Hospital, New York, NY for patients, family,
friends and medical professionals. The guest speaker was Irvin
M. Modlin., M.D., Ph.D., F.R.C.S from Yale University School
of Medicine, New Haven, CT. Most of the content of his presentation
was recently published and can be accessed by CLICKING
HERE. Additional medical journal publications by Dr. Modlin
are available in abstract form from PUB
MED - CLICK HERE
A NETWORKING/SUPPORT/AWARENESS interactive session was also held
to encourage patients and families to become a patient advocate
ENETS
(The European Neuroendocrine Tumor Society) is proud to announce
results from its 2007 conference: The 4th Annual ENETS Conference
was held in Barcelona, Spain, 15-17 March 2007. The
conference covered topics such as the application of the ENETS
Guidelines to clinical practice; rare hereditary diseases and
endocrine tumors; NET imaging and surgery; and new therapies
and clinical trials. A summary of this conference can be viewed
in their latest NEWS
LETTER.
ENETS' Board of Directors
